Supernus Pharmaceuticals Announces Participation in Upcoming June Investor Conferences New York Times Pips Puzzle Subscriber Engagement Trends in Digital Word Games Olenox Industries Unveils Strategic Corporate Update Amid Energy Sector Evolution Diversified Energy Acquires Maverick Natural Resources in Permian Basin Deal Fed Rate Cut Prospects Diminish as April Jobs Report Signals Labor Market Stability Nvidia Boosts Dividend and Buybacks Amid Surging Free Cash Flow Valuation Could Offer Upside Minerva Neurosciences Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Faces Challenges ASUR Q1 2026 Earnings EPS Beats Estimates by 183 as Revenue Details Remain Under Wraps Prudential Financial PRS Q1 2026 Earnings Strong Earnings Beat Signals Solid Operating Performance Ethan Allen Interiors Inc ETD Q1 2026 Earnings EPS Beats Estimates by 159 Stock Rises HSHP Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions Amplitech Group Inc AMPGR Q1 2026 Earnings EPS Misses Estimates Amid Stock Surge Shattuck Labs STTK Holds Near Support as Biotech Sentiment Shifts Anika Therapeutics Edges Higher as Stock Tests Key Resistance Zone National Energy Services Reunited NESR Declines 38 as Selling Pressure Intensifies Wolverine World Wide WWW Footwear Stock Surges 457 as Momentum Builds Nutex Health NUTX Surges 483 as Bullish Momentum Targets Key Resistance Piper Sandler Raises AbbVie Price Target on IBD Pipeline Advances RDWR Q1 2026 Earnings EPS Misses Estimates Stock Declines 298 Azenta Inc AZTA Rallies 159 as Stock Tests Key Technical Levels Eagle Point Credit Notes ECCW Steady Near Par as FixedIncome Market Consolidates Jade Biosciences Inc JBIO Faces Headwinds Shares Slide 533 as Key Support Levels Are Tested Day One Biopharmaceuticals DAWN Holds Steady at 2153 Consolidating Between Key Levels Guardian Pharmacy Services GRDN Gains Ground as Stock Pushes Toward Key Resistance RELX PLC RELX Edges Lower Amid Sector Headwinds Key Support at 3129 in Focus Addex Therapeutics ADXN Holds Gains Amid Biotech Sector Momentum Agios Pharmaceuticals Holds Steady Near 28 as Trading Activity Remains Subdued